Oxford NanoLabs, founded in 2005, is developing nanopore technology for use in DNA sequencing, where it potentially offers significant advantages in cost and speed over existing technologies.
Following completion of the financing round, IP Group has a 35% beneficial stake in Oxford NanoLabs, valued at £19.5 million. IP Group has invested £1 million in the financing alongside investment of £1.4 million from funds managed by Top Technology Ventures Limited, a subsidiary of IP Group. The remaining £7.6 million was raised from institutional and private investors.
The fundraising will result in a total fair value gain to IP Group of £7.2 million.
For further information, please contact:
IP Group plc 0845 0742929 Alan Aubrey, Chief Executive Officer Liz Vaughan-Adams (Communications) 020 7444 0062/07979853802
Financial Dynamics Ben Atwell, Rob Bailhache, Sanjeev Pandya 020 7831 3113
Oxford NanoLabs Dr Gordon Sanghera, Chief Executive Officer 0870 486 1966 Zoe McDougall (Communications)